Advent Takes Stake in Argentina's LKM

Advent Takes Stake in Argentina's LKM

Argentina Funds M&A

Private equity firm Advent has bought a majority stake in Argentine specialty pharmaceutical firm Laboratorio LKM for an undisclosed sum from the founding Kampel family. Under the agreement both parties will together contribute ARP50m ($12m) for expansion plans that include the building of a plant to export products to Europe. Advent has invested in this sector before in Argentina, where it held a stake in Fada Pharma, a manufacturer of generic pharmaceuticals for the institutional market. The e

Already have an account?

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial